Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
about
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trialHIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection.Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theInteractions between malaria and human immunodeficiency virus anno 2014"Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsThe influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatmentNevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults.The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.Global HIV/AIDS Clinical and Translational PharmacologyArtemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySignificant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsDevelopment of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionConcomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa.PXR antagonists and implication in drug metabolism.Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.Breakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine.Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapyPotential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.Coartem(®): a decade of patient-centric malaria management.CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in -negative HIV-infected Malawian adults stabilized on antiretroviral therapyMalaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies
P2860
Q28543154-1F4A8B26-949D-4A42-BF29-EE1492A36E3DQ30392186-30087CC4-6D7E-43F9-9C71-A04FEE33175EQ33733033-56C39B93-2DB3-4572-AC2A-4F489DCFED7DQ34149022-9731861E-680F-445E-AE7E-E8C706CC5E84Q34212799-83ED3452-EA0E-407E-9A2C-B4B11E68C995Q34404275-F3C7F8BD-EF27-4601-8C03-58D191EE3C66Q34996394-24086BBA-08A2-4AFB-9EDC-DC22160988D9Q35286119-31B33CE9-ECB0-4ECA-ACD7-9722DA34D156Q35583982-42BDC96B-D5FF-4420-AA22-10C2D5344E5FQ35829744-B5F9521F-22D7-45D4-92D6-AC41556B9DC5Q35906361-66A7285D-252C-43B2-AADF-50B71E3F8E88Q36125023-45B212C7-7225-477A-AADB-79B6B403D2E7Q36290691-3D3C6CF6-4080-4D94-B017-2256D2BA49B9Q36300127-34BCF686-1F9C-420C-BFAB-EA2FED753451Q36320042-7BE31AB8-F81C-42CB-A604-A242E64F924FQ36438820-ECF997AF-3A8B-45C5-81E6-D076811100B5Q36504556-9DB61665-A533-40F0-9E03-1320E9EDE53CQ36640752-A2D3A8CA-7698-462C-B927-E1AAECF9ADD2Q37279764-7D17747B-076C-4BD9-AE3D-A4B329941FC3Q37617809-15414266-6B7F-423D-9E09-9217C16814F1Q37688260-A498D949-64FD-447B-9A2F-1B33A469477AQ37696834-2A33B34A-4A20-47FF-AB2A-66AF7C85401DQ38155450-DD0144CD-AC95-469C-AAA6-65CC6144460AQ39042892-0AC49096-4A30-4BE0-826A-FB46717C1198Q41240864-68056AE7-6334-49CF-8290-698E5977B647Q42712939-7820EDD5-8BDD-4170-BA48-0AE085D0C6C5Q43418234-E703E40E-DDC8-4AC0-8F14-C735B2BF921AQ46398741-087BCC2A-71B2-428C-AFA5-4A96A82A4C3EQ51365463-473340CF-9BF4-4FEC-881C-9AF7EF23D810Q52609473-4E342375-04E7-4B19-86D9-5655A565E6B0Q56339581-C27417B7-6EAC-4B59-8AF2-B47B775A4197Q56355771-2B94733F-41AD-4848-8786-716B4B2AEE59
P2860
Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Interaction between artemether ...... py in HIV-1-infected patients.
@ast
Interaction between artemether ...... py in HIV-1-infected patients.
@en
type
label
Interaction between artemether ...... py in HIV-1-infected patients.
@ast
Interaction between artemether ...... py in HIV-1-infected patients.
@en
prefLabel
Interaction between artemether ...... py in HIV-1-infected patients.
@ast
Interaction between artemether ...... py in HIV-1-infected patients.
@en
P2093
P2860
P50
P356
P1476
Interaction between artemether ...... apy in HIV-1-infected patients
@en
P2093
J S Van der Walt
P2860
P304
P356
10.1128/AAC.05265-11
P407
P577
2011-09-26T00:00:00Z